170 related articles for article (PubMed ID: 32812830)
1. Animal models of Chagas disease and their translational value to drug development.
Chatelain E; Scandale I
Expert Opin Drug Discov; 2020 Dec; 15(12):1381-1402. PubMed ID: 32812830
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic screening approaches for Chagas disease drug discovery.
Chatelain E; Ioset JR
Expert Opin Drug Discov; 2018 Feb; 13(2):141-153. PubMed ID: 29235363
[TBL] [Abstract][Full Text] [Related]
3. Translational challenges of animal models in Chagas disease drug development: a review.
Chatelain E; Konar N
Drug Des Devel Ther; 2015; 9():4807-23. PubMed ID: 26316715
[TBL] [Abstract][Full Text] [Related]
4. Why hasn't there been more progress in new Chagas disease drug discovery?
Vermelho AB; Rodrigues GC; Supuran CT
Expert Opin Drug Discov; 2020 Feb; 15(2):145-158. PubMed ID: 31670987
[No Abstract] [Full Text] [Related]
5. The translational challenge in Chagas disease drug development.
Kratz JM; Gonçalves KR; Romera LM; Moraes CB; Bittencourt-Cunha P; Schenkman S; Chatelain E; Sosa-Estani S
Mem Inst Oswaldo Cruz; 2022; 117():e200501. PubMed ID: 35613156
[TBL] [Abstract][Full Text] [Related]
6. New drug discovery strategies for the treatment of benznidazole-resistance in
Murta SMF; Lemos Santana PA; Jacques Dit Lapierre TJW; Penteado AB; El Hajje M; Navarro Vinha TC; Liarte DB; de Souza ML; Goulart Trossini GH; de Oliveira Rezende Júnior C; de Oliveira RB; Ferreira RS
Expert Opin Drug Discov; 2024 Jun; 19(6):741-753. PubMed ID: 38715393
[TBL] [Abstract][Full Text] [Related]
7. Emerging agents for the treatment of Chagas disease: what is in the preclinical and clinical development pipeline?
Martínez-Peinado N; Cortes-Serra N; Losada-Galvan I; Alonso-Vega C; Urbina JA; Rodríguez A; VandeBerg JL; Pinazo MJ; Gascon J; Alonso-Padilla J
Expert Opin Investig Drugs; 2020 Sep; 29(9):947-959. PubMed ID: 32635780
[TBL] [Abstract][Full Text] [Related]
8. Drug discovery for chagas disease: A viewpoint.
Kratz JM
Acta Trop; 2019 Oct; 198():105107. PubMed ID: 31351074
[TBL] [Abstract][Full Text] [Related]
9. Novel drug discovery for Chagas disease.
Moraes CB; Franco CH
Expert Opin Drug Discov; 2016; 11(5):447-55. PubMed ID: 26967915
[TBL] [Abstract][Full Text] [Related]
10. Chagas disease drug discovery: toward a new era.
Chatelain E
J Biomol Screen; 2015 Jan; 20(1):22-35. PubMed ID: 25245987
[TBL] [Abstract][Full Text] [Related]
11. Therapeutical approaches under investigation for treatment of Chagas disease.
Bahia MT; Diniz Lde F; Mosqueira VC
Expert Opin Investig Drugs; 2014 Sep; 23(9):1225-37. PubMed ID: 24855989
[TBL] [Abstract][Full Text] [Related]
12. Detection and treatment of Trypanosoma cruzi: a patent review (2011-2015).
Rodriguez JB; Falcone BN; Szajnman SH
Expert Opin Ther Pat; 2016 Sep; 26(9):993-1015. PubMed ID: 27376456
[TBL] [Abstract][Full Text] [Related]
13. Effective drug discovery in Chagas disease.
Tarleton RL
Trends Parasitol; 2023 Jun; 39(6):423-431. PubMed ID: 37024318
[TBL] [Abstract][Full Text] [Related]
14. Advances in preclinical approaches to Chagas disease drug discovery.
Villalta F; Rachakonda G
Expert Opin Drug Discov; 2019 Nov; 14(11):1161-1174. PubMed ID: 31411084
[No Abstract] [Full Text] [Related]
15. Time and dose-dependence evaluation of nitroheterocyclic drugs for improving efficacy following Trypanosoma cruzi infection: A pre-clinical study.
Mazzeti AL; Diniz LF; Gonçalves KR; Nascimento AFS; Spósito PAF; Mosqueira VCF; Machado-Coelho GLL; Ribeiro I; Bahia MT
Biochem Pharmacol; 2018 Feb; 148():213-221. PubMed ID: 29309767
[TBL] [Abstract][Full Text] [Related]
16. Low-dose benznidazole treatment results in parasite clearance and attenuates heart inflammatory reaction in an experimental model of infection with a highly virulent Trypanosoma cruzi strain.
Cevey ÁC; Mirkin GA; Penas FN; Goren NB
Int J Parasitol Drugs Drug Resist; 2016 Apr; 6(1):12-22. PubMed ID: 26862474
[TBL] [Abstract][Full Text] [Related]
17. Selenium Derivatives as Promising Therapy for Chagas Disease:
Martín-Escolano R; Etxebeste-Mitxeltorena M; Martín-Escolano J; Plano D; Rosales MJ; Espuelas S; Moreno E; Sánchez-Moreno M; Sanmartín C; Marín C
ACS Infect Dis; 2021 Jun; 7(6):1727-1738. PubMed ID: 33871252
[TBL] [Abstract][Full Text] [Related]
18. Drug screening and development cascade for Chagas disease: an update of in vitro and in vivo experimental models.
Soeiro MNC; Sales-Junior PA; Pereira VRA; Vannier-Santos MA; Murta SMF; Sousa AS; Sangenis LHC; Moreno AMH; Boechat N; Branco FSC; Holetz FB; Ávila AR; Pereira MCS
Mem Inst Oswaldo Cruz; 2024; 119():e240057. PubMed ID: 38958341
[TBL] [Abstract][Full Text] [Related]
19. Potential new clinical therapies for Chagas disease.
Bustamante JM; Tarleton RL
Expert Rev Clin Pharmacol; 2014 May; 7(3):317-25. PubMed ID: 24716790
[TBL] [Abstract][Full Text] [Related]
20. Current advances in drug discovery for Chagas disease.
Scarim CB; Jornada DH; Chelucci RC; de Almeida L; Dos Santos JL; Chung MC
Eur J Med Chem; 2018 Jul; 155():824-838. PubMed ID: 30033393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
